These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30771350)

  • 1. Complement C3a receptor antagonist attenuates tau hyperphosphorylation via glycogen synthase kinase 3β signaling pathways.
    Hu J; Yang Y; Wang M; Yao Y; Chang Y; He Q; Ma R; Li G
    Eur J Pharmacol; 2019 May; 850():135-140. PubMed ID: 30771350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SLM, a novel carbazole-based fluorophore attenuates okadaic acid-induced tau hyperphosphorylation via down-regulating GSK-3β activity in SH-SY5Y cells.
    Wu X; Kosaraju J; Tam KY
    Eur J Pharm Sci; 2017 Dec; 110():101-108. PubMed ID: 28359686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morroniside-Induced PP2A Activation Antagonizes Tau Hyperphosphorylation in a Cellular Model of Neurodegeneration.
    Yang CC; Kuai XX; Gao WB; Yu JC; Wang Q; Li L; Zhang L
    J Alzheimers Dis; 2016; 51(1):33-44. PubMed ID: 26836014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of glycogen synthase kinase-3beta downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A.
    Martin L; Magnaudeix A; Esclaire F; Yardin C; Terro F
    Brain Res; 2009 Feb; 1252():66-75. PubMed ID: 19071093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproate reduces tau phosphorylation via cyclin-dependent kinase 5 and glycogen synthase kinase 3 signaling pathways.
    Hu JP; Xie JW; Wang CY; Wang T; Wang X; Wang SL; Teng WP; Wang ZY
    Brain Res Bull; 2011 May; 85(3-4):194-200. PubMed ID: 21435383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of PTEN inhibition on regulation of tau phosphorylation in an okadaic acid-induced neurodegeneration model.
    Chen Z; Chen B; Xu WF; Liu RF; Yang J; Yu CX
    Int J Dev Neurosci; 2012 Oct; 30(6):411-9. PubMed ID: 22906543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effect of paeoniflorin on okadaic acid-induced tau hyperphosphorylation via calpain/Akt/GSK-3β pathway in SH-SY5Y cells.
    Ma XH; Duan WJ; Mo YS; Chen JL; Li S; Zhao W; Yang L; Mi SQ; Mao XL; Wang H; Wang Q
    Brain Res; 2018 Jul; 1690():1-11. PubMed ID: 29596798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The new indirubin derivative inhibitors of glycogen synthase kinase-3, 6-BIDECO and 6-BIMYEO, prevent tau phosphorylation and apoptosis induced by the inhibition of protein phosphatase-2A by okadaic acid in cultured neurons.
    Martin L; Magnaudeix A; Wilson CM; Yardin C; Terro F
    J Neurosci Res; 2011 Nov; 89(11):1802-11. PubMed ID: 21826701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microcystin-Leucine-Arginine Induces Tau Pathology Through Bα Degradation via Protein Phosphatase 2A Demethylation and Associated Glycogen Synthase Kinase-3β Phosphorylation.
    Zhang Y; Zhang J; Wang E; Qian W; Fan Y; Feng Y; Yin H; Li Y; Wang Y; Yuan T
    Toxicol Sci; 2018 Apr; 162(2):475-487. PubMed ID: 29228318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Okadaic acid-induced Tau phosphorylation in rat brain: role of NMDA receptor.
    Kamat PK; Rai S; Swarnkar S; Shukla R; Ali S; Najmi AK; Nath C
    Neuroscience; 2013 May; 238():97-113. PubMed ID: 23415789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation.
    Jämsä A; Hasslund K; Cowburn RF; Bäckström A; Vasänge M
    Biochem Biophys Res Commun; 2004 Jul; 319(3):993-1000. PubMed ID: 15184080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptotanshinone Attenuates Amyloid-β
    Lyu D; Jia J
    Mol Neurobiol; 2022 Jul; 59(7):4488-4500. PubMed ID: 35575872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Okadaic acid induces tau phosphorylation in SH-SY5Y cells in an estrogen-preventable manner.
    Zhang Z; Simpkins JW
    Brain Res; 2010 Jul; 1345():176-81. PubMed ID: 20457142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DHCR24 Knockdown Lead to Hyperphosphorylation of Tau at Thr181, Thr231, Ser262, Ser396, and Ser422 Sites by Membrane Lipid-Raft Dependent PP2A Signaling in SH-SY5Y Cells.
    Qi Z; Zhang Y; Yao K; Zhang M; Xu Y; Zhang J; Bai X; Zu H
    Neurochem Res; 2021 Jul; 46(7):1627-1640. PubMed ID: 33710538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compound C enhances tau phosphorylation at Serine
    Majd S; Koblar S; Power J
    Neurosci Lett; 2018 Mar; 670():53-61. PubMed ID: 29398519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine A
    Zhao ZA; Zhao Y; Ning YL; Yang N; Peng Y; Li P; Chen XY; Liu D; Wang H; Chen X; Bai W; Chen JF; Zhou YG
    Transl Psychiatry; 2017 May; 7(5):e1123. PubMed ID: 28485728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-124-3p attenuates hyperphosphorylation of Tau protein-induced apoptosis via caveolin-1-PI3K/Akt/GSK3β pathway in N2a/APP695swe cells.
    Kang Q; Xiang Y; Li D; Liang J; Zhang X; Zhou F; Qiao M; Nie Y; He Y; Cheng J; Dai Y; Li Y
    Oncotarget; 2017 Apr; 8(15):24314-24326. PubMed ID: 28186985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B vitamin deficiency promotes tau phosphorylation through regulation of GSK3beta and PP2A.
    Nicolia V; Fuso A; Cavallaro RA; Di Luzio A; Scarpa S
    J Alzheimers Dis; 2010; 19(3):895-907. PubMed ID: 20157245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cornel Iridoid Glycoside Inhibits Tau Hyperphosphorylation via Regulating Cross-Talk Between GSK-3β and PP2A Signaling.
    Yang C; Li X; Gao W; Wang Q; Zhang L; Li Y; Li L; Zhang L
    Front Pharmacol; 2018; 9():682. PubMed ID: 29997510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-Reactive Protein Induces Tau Hyperphosphorylation via GSK3β Signaling Pathway in SH-SY5Y Cells.
    Guo H; Wang H; Wang C; Cheng Y; Zou Z; Li Y; Wu J; Xu J
    J Mol Neurosci; 2015 Jun; 56(2):519-27. PubMed ID: 25966642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.